Which treatments do children with newly diagnosed non-organic urinary incontinence receive? An analysis of 3,188 outpatient cases from Germany

Copyright © 2011 Wiley Periodicals, Inc.

Bibliographic Details
Published in:Neurourology and urodynamics, Vol. 31, No. 1 (2012), p. 93-8
Main Author: Hoffmann, Falk
Other Involved Persons: Steuber, Christian ; Günther, Judith ; Glaeske, Gerd ; Bachmann, Christian J
Format: electronic Article
Language:English
ISSN:1520-6777
Item Description:Date Completed 02.07.2012
Date Revised 19.11.2015
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.1002/nau.21177
Subjects:
QR Code: Show QR Code
LEADER 04621nma a2200829 c 4500
001 NLM210167416
003 DE-601
005 20181228061330.0
007 cr uuu---uuuuu
008 180205s2012 000 0 eng d
024 7 |a 10.1002/nau.21177  |2 doi 
028 5 2 |a pubmed19n0701.xml 
035 |a (DE-599)NLM21780174 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Hoffmann, Falk 
245 1 0 |a Which treatments do children with newly diagnosed non-organic urinary incontinence receive? An analysis of 3,188 outpatient cases from Germany  |h Elektronische Ressource 
300 |a Online-Ressource 
500 |a Date Completed 02.07.2012 
500 |a Date Revised 19.11.2015 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a Copyright © 2011 Wiley Periodicals, Inc. 
520 |a AIMS: Objectives of this study were to examine the administrative incidence of urinary incontinence in children and to assess related outpatient health services utilization in this cohort 
520 |a METHODS: Data of a statutory health insurance company were analyzed and outpatients from 1 to 18 years of age with a first recorded ICD-10 code for non-organic urinary incontinence during a 1-year-period (2007) were identified. For this cohort, the prescription of desmopressin, antispasmodics, non-selective monoamine reuptake inhibitors, alarm devices, and incontinence pads in the quarter of the first diagnosis and in the following one (i.e., 6 months) was evaluated with respect to age and gender 
520 |a RESULTS: 3,188 patients (59.4% male; mean age 6.8 years) matched the inclusion criteria, of whom 25.4% were under 5 years old. 7.9% were prescribed desmopressin, 7.4% received urinary antispasmodics, and 7.0% were treated with alarm devices. For 77.9% of patients, no specific incontinence-related treatments were prescribed. We found considerable differences in treatment patterns between age groups, with patients ≥ 7 years receiving desmopressin more frequently than alarm devices. Regarding gender differences, the proportion of males treated with alarm devices (prevalence ratio [PR] 1.46; 95% confidence interval [95%CI] 1.11-1.92) and at least one specific treatment (PR 1.19; 95%CI 1.04-1.35) remained statistically significantly higher, even after adjusting for age 
520 |a CONCLUSIONS: In our study, we found evidence that treatment modalities only partly comply with the current guidelines for treatment of children and adolescents with non-organic urinary incontinence. Therefore, the dissemination of current guidelines remains a major educational goal 
611 2 7 |a Journal Article  |2 gnd 
653 2 |a Adolescent  |6 D000293 
653 2 |a Age Factors  |6 D000367 
653 2 |a Antidiuretic Agents  |6 D050034  |a therapeutic use  |6 Q000627 
653 2 |a Child  |6 D002648 
653 2 |a Child, Preschool  |6 D002675 
653 2 |a Clinical Alarms  |6 D056902 
653 2 |a Cohort Studies  |6 D015331 
653 2 |a Deamino Arginine Vasopressin  |6 D003894  |a therapeutic use  |6 Q000627 
653 2 |a Female  |6 D005260 
653 2 |a Germany  |6 D005858  |a epidemiology  |6 Q000453 
653 2 |a *Guideline Adherence  |6 D019983 
653 2 |a Humans  |6 D006801 
653 2 |a Incidence  |6 D015994 
653 2 |a Incontinence Pads  |6 D016496 
653 2 |a Infant  |6 D007223 
653 2 |a Male  |6 D008297 
653 2 |a *Outpatients  |6 D010045 
653 2 |a Parasympatholytics  |6 D010276  |a therapeutic use  |6 Q000627 
653 2 |a *Practice Patterns, Physicians'  |6 D010818 
653 2 |a Retrospective Studies  |6 D012189 
653 2 |a Sex Factors  |6 D012737 
653 2 |a Treatment Outcome  |6 D016896 
653 2 |a Urinary Incontinence  |6 D014549  |a *epidemiology  |6 Q000453  |a *therapy  |6 Q000628 
655 7 |a Antidiuretic Agents  |2 gnd 
655 7 |a Parasympatholytics  |2 gnd 
655 7 |a Deamino Arginine Vasopressin  |2 gnd 
655 7 |a ENR1LLB0FP  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 |5 DE-601 
689 2 0 |a Antidiuretic Agents 
689 2 1 |a Parasympatholytics 
689 2 2 |a Deamino Arginine Vasopressin 
689 2 3 |A r  |a ENR1LLB0FP 
689 2 |5 DE-601 
700 1 |a Steuber, Christian 
700 1 |a Günther, Judith 
700 1 |a Glaeske, Gerd 
700 1 |a Bachmann, Christian J 
773 0 8 |i in  |t Neurourology and urodynamics  |g Vol. 31, No. 1 (2012), p. 93-8  |q 31:1<93-8  |w (DE-601)NLM074812122  |x 1520-6777 
856 4 1 |u http://dx.doi.org/10.1002/nau.21177  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |d 31  |j 2012  |e 1  |c 01  |h 93-8